While Bio-Techne has lagged behind the broader market over the past year, Wall Street analysts maintain a moderately ...

Shares of Bio-Techne Corp. TECH advanced 1.43% to $47.37 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.17% to 7,445.72 ...

Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Asset Fund”. A copy of ...

Bio-Techne Corporation's ( NASDAQ:TECH ) earnings announcement last week didn't impress shareholders. However, ...

Detailed price information for Billiontoone Inc Cl A (BLLN-Q) from The Globe and Mail including charting and trades.

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Bio-Techne (TECH) and InMode (INMD). According to TipRanks.com, Boucher is ranked #8907 out of 12228 ...

Q3 fiscal 2026 Management View "The Bio-Techne team continued to execute with discipline in a dynamic and uneven end market environment" and said results were supported by "sustained strength from our ...

Life sciences company Bio-Techne (NASDAQ:TECH) fell short of the market’s revenue expectations in Q1 CY2026, with sales falling 1.5% year on year to $311.4 million. Its non-GAAP profit of $0.53 per ...

Use of Non-GAAP Financial Measures: This press release contains financial measures that have not been calculated in accordance with accounting principles generally accepted in the U.S. (GAAP). We ...

Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended March 31, 2026. The quarterly dividend will be ...

Bio-Techne introduces a streamlined brand architecture that organizes its technologies into three focused portfolio brands: R&D Systems™, Bio-Techne Spatial™, and Bio-Techne Diagnostics™. The new ...